The scientific study of the analysis of CBD oil got a major push recently. It's been almost 40 years since the last thorough toxicological safety assessment was run on a CBD oil. However, recently CV sciences had AIBMR Life Sciences Inc. perform a complete array of toxicological studies on Plus CBD oil, the company's consumer-lauded hemp cannabidiol oil. The study attested to the safety of oral consumption of the product.

The study conclusions, which have been shared in a peer-reviewed journal, attest to the fact that the oil was discovered to be non-clastogenic, non-mutagenic and non-genotoxic. A spokesperson for CV Sciences noted that the company was "thrilled" and would encourage all CBD companies to allow such studies to be conducted for their own base materials.

Key Takeaways:

• CV Sciences Inc hired AIBMR Lifesciences Inc. to perform a full toxicological screening of CV's consumer-lauded CBD oil, specifically an extract from the base raw materials comprising it.
• A peer-reviewed journal has published the findings, which indicate that the extract tested is non-mutagenic, non-clastogenic and non-genotoxic.
• A spokesperson for CV Sciences indicated that the company was "thrilled" and also urged other CBD companies to have their base materials tested too.

"The toxicological assessment is the first known published data of its kind since the 1980 Rosenkrantz et al.’s publication with respect to toxicology data on CBD, Cannabichromene and hashish oil."

Read more: http://markets.businessinsider.com/news/stocks/cv-sciences-inc-announces-landmark-publication-on-the-toxicology-and-safety-assessment-of-base-material-of-its-pluscbd-oil-products-1027104828

Earth Science Tech has recently announced their discovery and development of three new advanced cannabis formulas. These functional food products that are developed are designed to alleviate typical symptoms and even prevent certain illnesses overall. The well being of individuals can also be improved with things such as brain function, diabetes, inflammation, or even immune cell function.

Key Takeaways:

• Another object of the present invention is to provide a method for activating the immune system. The method includes the stimulation of macrophages and the administration of the pharmaceutical compositions.
• Together, these diseases and disorders represent a massive market. Mental disorders are increasing worldwide.
• Another object of the present invention is to provide a method of modulating the immune system. The method includes the administration of the pharmaceutical compositions.

"ETST’s CBD-Nutraceutical (functional food) products are designed to alleviate common symptoms and prevent illnesses."

Reference:

https://www.google.com/url?rct=j&sa=t&url=https://globenewswire.com/news-release/2016/12/20/899140/0/en/Earth-Science-Tech-announces-the-Development-of-3-New-Advanced-Formulated-Cannabis-CBD-Nutraceuticals-and-2-Cannabis-CBD-Based-Pharmaceutical-Drugs-under-its-Cannabis-CBD-Patent-IP.html&ct=ga&cd=CAIyGmM2M2RhZjlmZTVmZDZjMmU6Y29tOmVuOlVT&usg=AFQjCNE09gWA5yC3tbP1hre_Gn2FN1mnwg

There is concern over a rumor that the DEA seeks to create a brand new schedule I class of drugs just for marijuana extracts, known as CBD. They must go through a scheduling action to get approval, but many are outraged over the possibility of losing access to any medicinal product made from Cannabis. This can include non-psychoactive drugs. Some are trying to soothe the panic by stating that it doesn’t include hemp products. As long as it is not a drug, it is not restricted. We will have to wait and see how this plays out.

Key Takeaways:

• The Final Rule published on December 14th was not a scheduling action but rather an administrative action related to record keeping
• Such action is an admission that the federal government is really just an obedient lapdog of the United Nations.
• That company plans to announce to its customers that they have 30 days to purchase their products, after which they plan to pull all sales except for inside their home state.

"Big Media, Big Pharma, Big Government, Big Banks and Big Agriculture are assaulting our bodies and minds by the hour, it seems."

Reference:

//www.naturalnews.com/2016-12-16-dea-quietly-announces-schedule-i-status-for-cbd-extracts-prohibition-begins-january-13-2017.html